The role of cisapride in the treatment of pediatric gastroesophageal reflux. The European Society of Paediatric Gastroenterology, Hepatology and Nutrition

Authors :: Vandenplas, Y
Belli, Dominique Charles
Benatar, A
Cadranel, S
Cucchiara, S
Dupont, C
Gottrand, F
Hassall, E
Heymans, H S
Kearns, G
Kneepkens, C M
Koletzko, S
Milla, P
Polanco, I
Staiano, A M
Source :: Journal of Pediatric Gastroenterology and Nutrition, Vol. 28, No 5 (1999) pp. 518-28
Publication Year :: 1999
Abstract: Cisapride is a gastrointestinal prokinetic agent that is used worldwide in the treatment of gastrointestinal motility-related disorders in premature infants, full-term infants, and children. Efficacy data suggest that it is the most effective commercially available prokinetic drug.

Subjects :: ddc:618
Cytochrome P-450 Enzyme System/metabolism
Arrhythmias, Cardiac/chemically induced
Mixed Function Oxygenases/metabolism
Gastroesophageal Reflux/drug therapy
Infant, Newborn
Infant
Cisapride/administration & dosage/adverse effects/therapeutic use
Risk Factors
Cytochrome P-450 CYP3A
Humans
Drug Interactions
Gastrointestinal Agents/administration & dosage/adverse effects/therapeutic use
Infant, Premature

Language :: English
ISSN :: 02772116
Database :: OpenAIRE
Journal :: Journal of Pediatric Gastroenterology and Nutrition, Vol. 28, No 5 (1999) pp. 518-28
Accession number :: edsair.od......1400..e434026d6fc965069cfa43a589d486b2

Tools